mixture contained 100 ng genomic DNA, 0.2 µM of each primer, 200 µM dNTP, 10 mM of Tris-HCL buffer (PH 8.3), 1.5 mM Mgcl 2 (PH 8.3) and 0.024 units of Taq polymerase enzyme in a final reaction volume of 15.0 µl. After initial denaturation at 95 0 C for 5 minutes, the DNA was amplified by 30 cycles of denaturation at 94 0 C for 45 seconds, annealing at 56 0 C for 45 seconds and primer extension at 72 0 C for 45 seconds. Final extension was performed at 72 0 C for 10 minutes. The amplified PCR products were separated by electrophoresis on 2% agarose gel and the DNA was visualized under UV transilluminator after staining with ethidium bromide. The insertion (I) allele was detected as band of 490 bp fragment and deletion (D) allele was identified as a band of 190 bp fragment. All the data were analyzed by SPSS 10.0. Two-tailed probability levels for statistical significance are reported. The relevant null hypothesis on odds ratio (Matched Pairs) in the present case is tested H 0 : OR M =1.
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RESULTS
Anthropometric and physiometric characteristics of the control and hypertensive subjects are presented in table I. The two study groups were well matched for sex, age and sample size. The mean systolic (SBP) and diastolic (DBP) blood pressures, BMI and WHR were significantly higher (P<0.001) among hypertensive both groups. The ACE genotype and allele frequencies distribution of control and hypertensive subjects are shown in table 2. The frequencies of II, ID and DD genotype among the control group were 26% (n=13), 54% (n=27) and 20% (n=10) respectively, whereas, in hypertensive group the same were found to be 22% (n=11), 32% (n=16) and 46% (n=23) respectively. There is significant difference (p<0.05) observed in the distribution of ACE genotype polymorphism between the two groups. It has been observed that the ACE DD genotype was significantly (p<0.05) higher in hypertensive subjects, whereas, ID genotype was significantly (p<0.05) higher in control subjects. The frequency of the D allele is also more frequent but not significant in hypertensive subjects than in control. The distribution of genotype frequencies associations of ACE gene polymorphisms between male and female among control and hypertensive subjects are given in table 3. The results showed that among three genotypes within control group, ID genotype was significantly more prevalent in male as compared to other two genotypes (odds ratio:3.0; CI: 0.152-5.84; χ 2 =14.0, P<0.001). Whereas, among female, II genotype is comparatively more prevalent but not significantly differ (odds ratio: 0.692; χ 2 =1.45, ns). In the hypertensive group, both male and female are more associated with DD genotype as compared to other two genotypes. However, these
DISCUSSION
In the present study, it has been investigated the association of ACE insertion/ deletion (I/D) polymorphism with hypertension among selected individuals from Bania (a business community) population in Punjab. The study was carried out ri ng hi gh per for man ce liquid chro ma tog rap hy, DHPLC). U uv je ti ma ko ji ni su de na tu ri ra ju ći, ona ana li zi ra PCR produ kt za pro bi ra nje I/D po li mor za ma u epi de mio loš kim genetskim is tra ži va nji ma (21). Ta me to da ot kla nja mo guć-no st pog reš nog od re đi va nja i nu di 100% toč no st kod I/D he te ro zi go ta, no zbog vi so kih troš ko va kro ma tog ra je nije is pla ti va.
E ec ts of I/D polymor phi sm on hu man heal th
The in uen ce of I/D po lymor phi sm on pat hop hysio lo gical con di tio ns me dia ted throu gh ACE ac ti vi ty has ge nera ted a lot of da ta showi ng its as so cia tion wi th se ve ral disea ses (Tab le 1). In the pre se nt re view, its ro le in de cidi ng Childhood Hypertension heart disease, stroke, renal disease, and congestive heart failure(3). Hypertension is usually described as primary (essential) or secondary due to a definable cause.
Prevalence of Primary and Secondary
The younger the patient and more severe the hypertension, the more likely that a secondary cause will be found.
Most acute hypertension in childhood is due to glomerulonephritis. Chronic hypertension is commonly associated with renal parenchymal disease and only a small proportion have renovascular hypertension, pheochromocytoma or coarctation of the aorta disorders including sleep apnea are associated with hypertension; approximately 15% of children snore, and 1-3% have sleepdisordered breathing. Repetitive loud snoring followed by silent periods of apnea usually represents the syndrome of obstructive sleep apnea. Because of the associations of hypertension with sleep disorders, particularly among overweight children, a history of sleeping patterns should be obtained(7).
Clinical Presentation
Young infants may present in acute Future studies will show whether all these associations and pathophysiological aspects of ACE and its basic geno-and pheno-types will lead not only to a better understanding of hypertension and/ or diabetes, as well as its many Previous studies revealed a strong association between ACE I/D polymorphism and hypertension (Katsuya etal.1995; Mastana and Nunn. 1997 ). There are also previous reports showing negative association between ACE genotypes and hypertension (Sagnella et al. 1999 specificity dipeptidyl carboxypeptidase and may also act on non-vasoactive peptides. There are two forms of ACE in humans, encoded by a single gene located on chromosome 17 at q23; it is 21 kb in length and contains 26 exons and 25 introns. The longer form, known as somatic ACE (sACE), is transcribed from exons 1-12 and 14-26, whereas the shorter (exons 4-11 and 17-24, respectively) are very similar in size and have similar codon phases at exon-intron boundaries. Each of the domains contains a catalytically active site characterized by a consensus zinc-binding motif (HEXXH in the single-letter amino-acid code, where X is any amino acid) and a glutamine nearer the carboxyl terminus that also binds Kobe J. Med. Sci., Vol. 51, No. 3, pp. 41-47, 2005 ACE Gene Polymorphism in Children with Nephrotic Syndrome in the Indonesian Population (ACE) is a key enzyme that converts inactive angiotensin I into a vasoactive and aldosterone-stimulating peptide angiotensin II. In some cases, the increase of ACE protein is responsible for the elevation of angiotensin II level. Elevated angiotensin II level makes deleterious effects on renal hemodynamics and induces
ACE Gene Insertion/Deletion Polymorphism Genotyping
Genomic DNA was extracted from whole blood using SepaGene Kit (Sanyo Junyaku Co., Ltd., Tokyo, Japan). PCR was carried out according to the method of Rigat B et al (8) . The sequences of the forward and reverse primers were: 5'-CTG GAG ACC ACT CCC ATC CTT TCT-3' and 5'-GAT GTG GCC ATC ACA TTC GTC AGA T-3', respectively (8). regulator of blood pressure and renal electrolyte homeostasis, and this system has also been implicated in the pathological changes of organ damage through modulation of gene expression, growth, fibrosis, and inflammatory response. 
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